Improved Outcome of Refractory/Relapsed Acute Myeloid Leukemia after Post-Transplantation Cyclophosphamide-Based Haploidentical Transplantation with Myeloablative Conditioning and Early Prophylactic Granulocyte Colony-Stimulating Factor–Mobilized Donor Lymphocyte Infusions
Open Access
- 1 October 2016
- journal article
- Published by Elsevier in Transplantation and Cellular Therapy
- Vol. 22 (10) , 1867-1873
Abstract
No abstract availableKeywords
This publication has 33 references indexed in Scilit:
- Factors that contribute to long-term survival in patients with leukemia not in remission at allogeneic hematopoietic cell transplantationJournal of Experimental & Clinical Cancer Research, 2011
- Factors predicting outcome after unrelated donor stem cell transplantation in primary refractory acute myeloid leukaemiaLeukemia, 2011
- Mycophenolic Acid Inhibits Natural Killer Cell Proliferation and Cytotoxic Function: A Possible Disadvantage of Including Mycophenolate Mofetil in the Graft-Versus-Host Disease Prophylaxis RegimenTransplantation and Cellular Therapy, 2011
- Donor selection for natural killer cell receptor genes leads to superior survival after unrelated transplantation for acute myelogenous leukemiaBlood, 2010
- Hematopoietic Stem-Cell Transplantation for Acute Leukemia in Relapse or Primary Induction FailureJournal of Clinical Oncology, 2010
- Independent prognostic factors for AML outcomeHematology-American Society Hematology Education Program, 2009
- Donor natural killer cell allorecognition of missing self in haploidentical hematopoietic transplantation for acute myeloid leukemia: challenging its predictive value.Blood, 2007
- Natural killer cell recognition of missing self and haploidentical hematopoietic transplantationSeminars in Cancer Biology, 2006
- Sequential Regimen of Chemotherapy, Reduced-Intensity Conditioning for Allogeneic Stem-Cell Transplantation, and Prophylactic Donor Lymphocyte Transfusion in High-Risk Acute Myeloid Leukemia and Myelodysplastic SyndromeJournal of Clinical Oncology, 2005
- Factors predicting response and graft-versus-host disease after donor lymphocyte infusions: a study on 593 infusionsBone Marrow Transplantation, 2003